News
-
-
-
-
PRESS RELEASE
Onco-Innovations' PKNP Technology Shown in Study to Demonstrate Low Toxicity and High Safety Profile
Onco-Innovations Limited announces successful preclinical study results of its second-generation nanoparticle formulation of PNKP Compound, showing enhanced inhibitor delivery with minimal toxicity for potential cancer therapy -
-
-
PRESS RELEASE
Onco-Innovations Provides Information Regarding Inka Health's USPTO Provisional Patent Application for AI-Powered Precision Medicine Platform, SynoGraph
Onco-Innovations subsidiary, Inka Health, files patent for AI platform SynoGraph, enhancing precision medicine and oncology drug development. SynoGraph leverages AI-driven causal inference for treatment optimization -
-
-